Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 1, 2011, Pages 57-65

  Casas, Susana ^a,b   Andreu, Ana ^a   Juanola, Xavier ^a   Bordas, Xavier ^a,b   Alcaide, Fernando ^a,b,c   Moure, Raquel ^a   Anibarro, Luis ^d   Cuchí, Eva ^e   Esteve, Maria ^e   Ortiz, Vera ^f   Guerra, Maria Rosario ^a   Rodríguez, Jesus ^a   Reina, Delia ^a   Salvador, Georgina ^e   Guardiola, Jordi ^a   Surís, Xavier ^f   Pascual, Maria Angeles ^d   Martí, Carmina ^g   Martínez Lacasa, Xavier ^e   Cuquet, Jordi ^g   Gonzalez, Lucia ^a   Santin, Miguel ^a,b,c   more..

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c REIPI   (Spain)

^d HOSPITAL MONTECELO   (Spain)

^e HOSPITAL MÚTUA DE TERRASSA   (Spain)

^f Rheumatology Department   (Spain)

^g Fundació Hospital Asil of Granollers   (Spain)

Author keywords

Anti TNF ; Chronic inflammatory diseases; Interferon gamma release assays (IGRA); Interferon ; Tuberculosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; EFALIZUMAB; GAMMA INTERFERON; LEFLUNOMIDE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TUBERCULIN TEST; VOLUNTEER;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051617603     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.12.020     Document Type: Article

References (35)

1. Aichelburg M.C., Rieger A., Breitenecker F., Pfistershammer K., Tittes J., Eltz S., Aichelburg A.C., Stingl G., Makristathis A., Kohrgruber N. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin. Infect. Dis. 2009, 48:954-962.
2. Arend S.M., Thijsen S.F.T., Leyten E.M.S., Bouwman J.J.M., Franken W.P.J., Koster B.F.P., Cobelens F.G.J., van Houte A.J., Bossink A.W.J. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care Med. 2007, 175:618-627.
3. Bartalesi F., Vicidomini S., Goletti D., Fiorelli C., Fiori G., Melchiorre D., Tortoli E., Mantella A., Benucci M., Girardi E., Cerinic M.M., Bartoloni A. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur. Respir. J. 2009, 33:586-593.
4. Bocchino M., Matarese A., Bellofiore B., Giacomelli P., Santoro G., Balato N., Castiglione F., Scarpa R., Perna F., Signoriello G., Galati D., Ponticiello A., Sanduzzi A. Performance of two commercial blood IFN-gamma release assays for detection of Mycobacterium tuberculosis infection in patients candidates for anti-TNF-alpha treatment. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27:907-913.
5. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. Thorax 2005, 60:800-805. British Thoracic Society standards of Care Committee.
6. Carmona L., Gómez-Reino J.J., Rodríguez-Valverde V., Montero M.D., Pascual-Gómez E. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 2005, 52:1766-1772. (BIOBADASER Group).
7. Chen D.Y., Shen G.H., Hsieh T.Y., Hsieh C.W., Lan J.L. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum. 2008, 59:800-806.
8. Diel R., Loddenkemper R., Nienhaus A. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB: a meta-analysis. Chest 2010, 137:952-968.
9. Diel R., Loddenkemper R., Niemann S., Meywald-Walter K., Nienhaus A. Negative and positive predictive value of a whole-blood IGRA for developing active TB-an update. Am. J. Respir. Crit. Care Med. 2010, 10.1164/rccm.201006-0974OC.
10. Ferrara G., Losi M., Meacci M., Meccugni B., Piro R., Roversi P., Bergamini B.M., D'Amico R., Marchegiano P., Rumpianesi F., Fabbri L.M., Richeldi L. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005, 172:631-635.
11. Global Tuberculosis Control Global Tuberculosis Control: surveillance, planning, financing. WHO report 2007 2007, World Health Organization, Geneva, (WHO/HTM/TB/2007.376).
12. Gogus F., Günendi Z., Karakus R., Erdogan Z., Hizel K., Atalay F. Comparison of tuberculin skin test and QuantiFERON-TB gold in tube in patients with inflammatory diseases living in a tuberculosis endemic population. Clin. Exp. Med. 2009, 10.1007/s10238-009-0082-9.
13. Gómez-Reino J.J., Carmona L., Rodríguez V., Martín E., Montero M.D. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in Tuberculosis risk. Arthritis Rheum. 2003, 48:2122-2127. (BIOBADASER Group).
14. Gómez-Reino J.J., Carmona L., Descalzo M.A. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum. 2007, 57:756-761.
15. Greenberg J.D., Reddy S.M., Schloss S.G., Kurucz O.S., Bartlett S.J., Abramson S.B., Bingham C.O. Comparison of an in vitro tuberculosis interferon-γ assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis. J. Rheum. 2008, 35:1-6.
16. Inanc N., Aydin S.Z., Karakurt S., Atagunduz P., Yavuz S., Direskeneli H. Agreement between QuantiFERON-TB Gold Test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis. J. Rheum. 2009, 36:2675-2681.
17. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., Siegel J.N., Braun M.M. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 2001, 345:1098-1104.
18. Kobashi Y., Mouri K., Obase Y., Fukuda M., Miyashita N., Oka M. Clinical evaluation of QuantiFERON TG-2G test for immunocompromised patients. Eur. Respir. J. 2007, 30:945-950.
19. Lalvani A., Millington K.A. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun. Rev. 2008, 8:147-152.
20. Latorre I., De Souza-Galvao M., Ruiz-Manzano J., Lacoma A., Prat C., Altet N., Ausina V., Dominguez J. Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur. Respir. J. 2010, 35:338-342.
21. Leyten E.M.S., Arend S.M., Prins C., Cobelens F.G., Ottenhoff T.H., van Dissel J.T. Discrepancy between tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007, 14:880-885.
22. Malaviya A.N., Kapoor S., Garg S., Rawat R., Shankar S., Nagpal S., Khanna D., Furst D.E. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-α inhibitors in India-an audit report. J. Rheum. 2009, 36:1414-1420.
23. Matulis G., Jüni P., Villinger P.M., Gadola S.D. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon-γ assay. Ann. Rheum. Dis. 2008, 67:84-90.
24. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 2007, 146:340-354.
25. Nienhaus A., Schablon A., Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection-analysis of discordant results when compared to the tuberculin skin test. PloS One 2008, 3:e2665.
26. Ponce de León D., Acevedo-Vasquez E., Sánchez-Torres A., Cucho M., Alfaro J., Perich R., Pastor C., Harrison J., Sánchez-Schwartz C. Attenuated response to purified protein derivative in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2005, 64:1360-1361.
27. Ponce de Leon D., Acevedo-Vasquez E., Alvizuri S., Gutierrez C., Cucho M., Alfaro J., Perich R., Sanchez-Torres A., Pastor C., Sanchez-Schwartz C., Medina M., Gamboa R., Ugarte M. Comparison of an interferon-γ assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J. Rheum. 2008, 35:776-781.
28. Rangaka M.X., Wilkinson K.A., Seldon R., Van Cutsem G., Meintjes G.A., Morroni C., Mounton P., Diwakar L., Connell T.G., Maartens G., Wilkinson R.J. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2007, 175:514-520.
29. Schatz M., Patterson R., Kloner R., Falk J. The prevalence of tuberculosis and positive tuberculin skin tests in steroid-treated asthmatic population. Ann. Intern. Med. 1976, 84:261-265.
30. Schoepfer A.M., Flogerzi B., Fallegger S., Schaffer T., Mueller S., Nicod L., Seibold F. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. Am. J. Gastroenterol. 2008, 103:2799-2806.
31. Shovmen O., Anouk M., Vinnitsky N., Arad U., Paran D., Litinsky I., Caspi D., Elkayam O. QuantiFERON-B Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study. Int. J. Tuberc. Lung Dis. 2009, 13:1427-1432.
32. Stephan C., Wolf T., Goetsch U., Bellinger O., Nisius G., Oremek G., Rakus Z., Gottschalk R., Sark S., Brodt H.R., Staszewski S. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008, 22:2471-2479.
33. Vassilopoulos D., Stamoulis N., Hadziyannis E., Archimandritis A.J. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J. Rheum. 2008, 35:1271-1276.
34. Wallis R.S., Broder M.S., Wong J.Y., Hanson E., Beenhouwer D.O. Granulomatous infection diseases associated with tumor necrosis factor antagonists. Clin. Inf. Dis. 2004, 38:1261-1265.
35. Wang L., Turner M.O., Elwood R.K., Schulzer M., Fitzgerald J.M. A meta-analysis of the effect of bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002, 57:804-809.